Document 1236
 DOCN  M9591236
 TI    [Ophthalmological manifestations in AIDS: evaluation of 445 patients in
       one year]
 DT    9509
 AU    Muccioli C; Belfort Junior R; Lottenberg C; Lima J; Santos P; Kim M; de
       Abreu MT; Neves R; Departamento de Oftalmologia da Escola Paulista de
       Medicina, Sao; Paulo.
 SO    Rev Assoc Med Bras. 1994 Jul-Sep;40(3):155-8. Unique Identifier :
       AIDSLINE MED/95307586
 AB    The authors prospectively evaluated 445 HIV positive patients for the
       presence of ophthalmological manifestations. PURPOSE--To evaluate
       patients HIV positive with or without AIDS and correlate the data with
       the ocular findings mentioned in the literature. METHODS--445 HIV
       positive patients (66% with AIDS) were evaluated in one year at the
       Paulista School of Medicine, Sao Paulo Hospital, Brazil. There was a
       predominance of males (87%) and homosexuals (58.2%). RESULTS--Of the 445
       patients, 52% presented ocular findings secondary to HIV infection at
       the first examination. The diagnosis included: CMV retinitis (25%),
       ocular toxoplasmosis (8.5%), herpes retinitis (3.6%), papilledema
       (2.2%), optic atrophy (1.6%), phthisis bulbi (1.5%), multifocal
       choroiditis (1.2%), retinal hemorrhages (0.9%), syphilitic uveitis
       (0.6%) and central vein occlusion (0.2%). CONCLUSION--The incidence of
       ophthalmic manifestations of AIDS in Brazil is similar to that found in
       the international literature. We found though a higher incidence of
       ocular toxoplasmosis than that in other countries. No ocular
       pneumocystosis was presents in the population evaluated by us.
 DE    Acquired Immunodeficiency Syndrome/*COMPLICATIONS  AIDS-Related
       Opportunistic Infections/COMPLICATIONS/*EPIDEMIOLOGY  English Abstract
       Eye Diseases/COMPLICATIONS/*EPIDEMIOLOGY  Female  Human  HIV
       Seropositivity/*COMPLICATIONS  Male  Prospective Studies  JOURNAL
       ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).